Avinger (NASDAQ:AVGR) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGRFree Report) in a research report sent to investors on Friday. The firm issued a hold rating on the medical device company’s stock.

Avinger Stock Performance

Avinger stock opened at $0.47 on Friday. Avinger has a 1 year low of $0.36 and a 1 year high of $5.45. The firm has a 50 day moving average price of $0.67 and a 200 day moving average price of $0.88. The company has a market cap of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09.

Avinger Company Profile

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Read More

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.